← Back to Clinical Trials
Recruiting NCT07747961

NCT07747961 Effect of Virtual Reality Mediated Gamified Rehabilitation in Children With Spastic Diplegic Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07747961
Status Recruiting
Phase —
Sponsor Ibadat International University, Islamabad
Condition Spastic Diplegic Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2026-03-03
Primary Completion 2026-08-30

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
Experimental GroupControl

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2026-03-03 with a primary completion date of 2026-08-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial aimed to evaluate the effectiveness of a Virtual Reality (VR)-mediated gamified rehabilitation program compared with conventional physical therapy in children with spastic diplegic cerebral palsy. Forty-two children aged 7-15 years with Gross Motor Function Classification System (GMFCS) Levels II and III were recruited from Rafsan Neuro Rehab Center, Peshawar. Participants were randomly allocated into two equal groups. The intervention group received VR-based gamified rehabilitation using Xbox Kinect along with physiotherapy, while the control group received conventional physiotherapy only. Both groups completed 18 treatment sessions over six weeks. Outcome measures included the Timed Up and Go Test (TUG), Pediatric Balance Scale (PBS), Trunk Impairment Scale (TIS), and Gross Motor Function Classification System (GMFCS). The findings demonstrated that VR-mediated rehabilitation significantly improved functional mobility, balance, and trunk control compared with conventional therapy. The study concludes that VR-based rehabilitation is an effective, motivating, and clinically useful intervention for children with spastic diplegic cerebral palsy and may improve rehabilitation outcomes and functional independence.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with spastic diplegic cerebral palsy. * Age between 7-15 years. * GMFCS Level II or III. * Male and female participants. * Able to follow verbal instructions. Exclusion Criteria * Other neurological disorders. * Visual or hearing impairment. * Other types of cerebral palsy. * Severe cardiac disease. * Orthopedic surgery within previous six months. * Recent Botulinum toxin injection. * Children taking antispastic or antiepileptic medication. * Uncooperative participants.

Contact & Investigator

Central Contact

Hafsah Arshad, Phd*

✉ hafsah.arshad@uipt.iiui.edu.pk

📞 03315165234

Principal Investigator

Hafsah Arshad

PRINCIPAL INVESTIGATOR

Ibadat International University, Islamabad

Frequently Asked Questions

Who can join the NCT07747961 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 15 Years, studying Spastic Diplegic Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07747961 currently recruiting?

Yes, NCT07747961 is actively recruiting participants. Contact the research team at hafsah.arshad@uipt.iiui.edu.pk for enrollment information.

Where is the NCT07747961 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07747961 clinical trial?

NCT07747961 is sponsored by Ibadat International University, Islamabad. The principal investigator is Hafsah Arshad at Ibadat International University, Islamabad. The trial plans to enroll 42 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology